Hospital Formulary Objection Handling Dialogue

Role: Specialty Biopharma Key Account Director experienced in health economics and formulary committee negotiations.

Context

• Health system or P&T network: {{payer_or_hospital_network}}
• Proprietary drug asset: {{drug_brand_name}}
• Indication and patient cohort: {{indication_focus}}
• Key economic objection: {{primary_economic_objection}}
• Superior clinical measure: {{clinical_endpoint_advantage}}
• Standard of care alternative: {{comparator_treatment}}

Task

Generate a structured objection-handling dialogue script for an account manager meeting a Pharmacy & Therapeutics (P&T) committee member to navigate budgetary resistance and secure formulary inclusion for {{drug_brand_name}}.

Method

1. Validate the committee member's budgetary concern without conceding on product price.
2. Pivot the discussion from unit acquisition cost to total cost of care within {{payer_or_hospital_network}}.
3. Present {{clinical_endpoint_advantage}} as a direct driver of reduced downstream hospital utilization compared to {{comparator_treatment}}.
4. Script an open-ended question that prompts the stakeholder to quantify their current readmission or complication expenses for {{indication_focus}}.
5. Introduce real-world evidence or health economics data points to dismantle {{primary_economic_objection}}.
6. Script a pathway for restricted formulary access or pilot sub-population approval if full unrestricted access is resisted.
7. Provide a clear summary closing statement requesting a formal review date at the next committee meeting.
8. Include brief coaching notes outlining rep body language and vocal inflection during the interaction.

Constraints

• MUST strictly adhere to approved label claims and economic health outcomes data standards.
• MUST NOT offer off-invoice inducements or unapproved discounts.
• Script MUST format conversations into clear alternating dialogue turns (Committee Member / Account Director).
• Keep total script length under 500 words to ensure rapid memorization and practical roleplay use.

Output format

• Section 1: Strategic Context & Objective (50 words)
• Section 2: Objection Handling Dialogue (Verbatim dialogue with explicit speaker labels, 250-350 words)
• Section 3: Compromise / Restricted-Use Fallback Script (75-100 words)
• Section 4: Rep Delivery & Inflection Coaching Notes (3-4 bullet points)

Self-review

• Ensure all variables ({{payer_or_hospital_network}}, {{drug_brand_name}}, {{indication_focus}}, {{primary_economic_objection}}, {{clinical_endpoint_advantage}}, {{comparator_treatment}}) appear correctly.
• Verify that the objection response uses an acknowledge-pivot-evidence-ask structure.
• Confirm no unapproved or non-compliant pharma promotional tactics are suggested.